comparemela.com

Latest Breaking News On - George polimenakos - Page 1 : comparemela.com

MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market

/PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized.

United statesGeorge polimenakosHealth canadaCannabis incTherapeutic goods administrationMedipharm labs corpHealth canada drug establishmentMedipharm labs beacon medicalPharm labsDrug establishment licenseBeacon medicalPink kushMedical australiaMedipharm labsBeacon medical australiaTilray brands australia

Tilray Brands, Inc : Tilray Medical Receives Verification From the Natural Health Science Foundation in Australia and New Zealand

Natural Health Science Foundation Assessment Further Verifies Tilray Medical's High-Quality Standard and its CBD100 Product for Clinical Trial UseSYDNEY, Australia, Aug. 23, 2022 (GLOBE NEWSWIRE) Tilray

United statesNew zealandNew south walesRaphael grossBerrin noorataGeorge polimenakosNigel pollardDenise faltischekCompany nasdaqZealand ministry of healthHead of internationalNatural health science foundation qualitySecurities exchangeNatural health science foundationTilray brands incHigh quality standard

Tilray receives approval for CBD oral solution in Australia and New Zealand

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) has now received some desired approval for its flagship commodity from a renowned non-profit organization dedicated to assessing the quality of natural health products.

New zealandGeorge polimenakosNigel pollardZealand ministry of healthToronto securities exchangeNatural health science foundationTilray brands incTilray brandsTilray medicalNew zealand ministryTilray purified oral solutionGeneral managerNatural health scienceToronto securities

Tilray Medical Receives Verification From the Natural Health Science Foundation in Australia and New Zealand

Tilray Medical, has received approval and verification from The Natural Health Science Foundation of its flagship product, Tilray Purified Oral Solution CBD100

United statesNew zealandNew south walesRaphael grossBerrin noorataGeorge polimenakosNigel pollardDenise faltischekCompany nasdaqZealand ministry of healthHead of internationalNatural health science foundation qualitySecurities exchangeNatural health science foundationTilray brands incTilray brands

Why Tilray Keeps Expanding and TLRY Stock Keeps Suffering

TLRY stock isn't necessarily an opportunity to buy the dip. Market forces will likely lead Tilray even lower before we see a recovery.

George polimenakosTherapeutic goods administrationGeneral managerTilray australia

vimarsana © 2020. All Rights Reserved.